Orchestra BioMed Holdings (OBIO) Treasury Shares (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Treasury Shares data on file, last reported at $3.7 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 93.08% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 93.08% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 9.84% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.7 million, up from $2.3 million in the prior quarter.
• Over the last five years, Treasury Shares for OBIO reached as high as $16.0 million in Q1 2022 and fell as low as $49237.0 in Q2 2023.
• Historically, Treasury Shares has averaged $4.0 million across 5 years, with a median of $2.3 million in 2025.
• Across the five-year window, Treasury Shares slumped 99.69% in 2023 and soared 4928.3% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $158589.0 in 2022, then jumped by 972.72% to $1.7 million in 2023, then grew by 23.12% to $2.1 million in 2024, then advanced by 9.84% to $2.3 million in 2025, then jumped by 61.68% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.7 million in Q1 2026, $2.3 million in Q4 2025, and $2.6 million in Q3 2025.